CellCyte Genetics Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Cost of Goods Sold (COGS) incl. D&A
156.20
54.00
15.70
14.50
16.20
Gross Income
156.20
54.00
15.70
14.50
16.20
SG&A Expense
1,172.40
561.80
291.10
118.10
107.90
EBIT
1,328.70
756.00
306.80
132.70
124.20
Unusual Expense
53.50
-
-
749.50
-
Non Operating Income/Expense
68.80
4.80
-
2.00
-
Interest Expense
76.50
38.50
52.60
33.00
39.90
Pretax Income
1,420.40
799.20
359.40
585.80
164.00
Consolidated Net Income
1,420.40
799.20
359.40
585.80
164.00
Net Income
1,420.40
799.20
359.40
585.80
164.00
Net Income After Extraordinaries
1,420.40
799.20
359.40
585.80
164.00
Net Income Available to Common
1,420.40
799.20
359.40
585.80
164.00
EPS (Basic)
0.02
0.01
-
0.01
0.00
Basic Shares Outstanding
66,488.40
73,697.10
75,834.20
82,329.50
82,329.50
EPS (Diluted)
0.02
0.01
0.00
0.01
0.00
Diluted Shares Outstanding
66,488.40
73,697.10
75,834.20
88,791.00
82,329.50
EBITDA
1,172.40
701.90
291.10
118.20
107.90
Other Operating Expense
-
140.10
-
-
-
About CellCyte Genetics
View Profile
